Extracellular macrophage migration inhibitory factor (MIF) downregulates adipose hormone-sensitive lipase (HSL) and contributes to obesity.

AMP activated protein kinase (AMPK) Adipose tissue Hormone-sensitive lipase (HSL) Macrophage migration inhibitory factor (MIF) Obesity c-Jun N-terminal kinase (JNK)

Journal

Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730

Informations de publication

Date de publication:
05 Nov 2023
Historique:
received: 15 08 2023
revised: 21 10 2023
accepted: 02 11 2023
pubmed: 8 11 2023
medline: 8 11 2023
entrez: 7 11 2023
Statut: aheadofprint

Résumé

Attenuation of adipose hormone sensitive lipase (HSL) may impair lipolysis and exacerbate obesity. We investigate the role of cytokine, macrophage migration inhibitory factor (MIF) in regulating adipose HSL and adipocyte hypertrophy. Extracellular MIF downregulates HSL in an autocrine fashion, by activating the AMPK/JNK signaling pathway upon binding to its membrane receptor, CD74. WT mice fed high fat diet (HFD), as well as mice overexpressing MIF, both had high circulating MIF levels and showed suppression of HSL during the development of obesity. Blocking the extracellular action of MIF by a neutralizing MIF antibody significantly reduced obesity in HFD mice. Interestingly, intracellular MIF binds with COP9 signalosome subunit 5 (Csn5) and JNK, which leads to an opposing effect to inhibit JNK phosphorylation. With global MIF deletion, adipocyte JNK phosphorylation increased, resulting in decreased HSL expression, suggesting that the loss of MIF's intracellular inhibitory action on JNK was dominant in Mif

Identifiants

pubmed: 37935315
pii: S2212-8778(23)00168-0
doi: 10.1016/j.molmet.2023.101834
pmc: PMC10700858
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101834

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All the authors declare that no potential conflicts of interest relevant to this article.

Références

PLoS One. 2013 Apr 29;8(4):e60560
pubmed: 23637753
Immunol Cell Biol. 2012 Aug;90(7):688-98
pubmed: 22064706
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17444-9
pubmed: 21969590
Biochem Biophys Res Commun. 2006 Feb 3;340(1):291-5
pubmed: 16364253
Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):203-10
pubmed: 18072017
Nat Rev Rheumatol. 2019 Jul;15(7):427-437
pubmed: 31197253
Nature. 2008 Jan 31;451(7178):578-82
pubmed: 18235500
N Engl J Med. 2014 Jun 12;370(24):2307-2315
pubmed: 24848981
Nature. 2000 Apr 6;404(6778):635-43
pubmed: 10766250
Anal Biochem. 2012 Jun 1;425(1):88-90
pubmed: 22425542
Mol Cell Biol. 2016 Jun 29;36(14):1961-76
pubmed: 27185873
J Clin Invest. 2018 Nov 1;128(11):4997-5007
pubmed: 30295645
J Lipid Res. 2002 Oct;43(10):1585-94
pubmed: 12364542
J Biol Chem. 2016 Jul 22;291(30):15881-95
pubmed: 27226569
J Agric Food Chem. 2007 Oct 17;55(21):8404-10
pubmed: 17880164
PLoS One. 2016 Sep 14;11(9):e0162167
pubmed: 27627109
Immunity. 2006 Oct;25(4):595-606
pubmed: 17045821
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7917-E7926
pubmed: 27872288
Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1182-95
pubmed: 12954598
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):787-92
pubmed: 10639158
Ecotoxicol Environ Saf. 2020 Feb;189:109937
pubmed: 31785945
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9354-9
pubmed: 12878730
Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E654-67
pubmed: 17077342
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7849-54
pubmed: 8755565
J Clin Invest. 2009 Dec;119(12):3807-16
pubmed: 19920350
JCI Insight. 2019 Jul 11;4(13):
pubmed: 31292300
J Immunol. 2007 Oct 15;179(8):5399-406
pubmed: 17911626
Front Immunol. 2015 Jun 15;6:308
pubmed: 26124760
Cell Biochem Biophys. 2013;67(3):819-28
pubmed: 23605455
Innate Immun. 2012 Feb;18(1):25-34
pubmed: 21088047
PLoS One. 2014 Nov 20;9(11):e113369
pubmed: 25412423
Sci Transl Med. 2021 Oct 20;13(616):eabg1210
pubmed: 34669443
J Lipid Res. 2011 Feb;52(2):221-36
pubmed: 21097823
Int J Mol Sci. 2018 Sep 19;19(9):
pubmed: 30235785
J Clin Endocrinol Metab. 2007 Jun;92(6):2292-9
pubmed: 17356053
J Biol Chem. 2002 Feb 15;277(7):4806-15
pubmed: 11717312
J Exp Med. 1994 Jun 1;179(6):1895-902
pubmed: 8195715
FASEB J. 2014 Dec;28(12):5136-47
pubmed: 25122558
Int J Obes (Lond). 2005 Jun;29(6):675-81
pubmed: 15795748
Exp Mol Med. 2015 May 01;47:e161
pubmed: 25930990
J Immunol. 2011 Jan 1;186(1):527-38
pubmed: 21106847
Arthritis Rheumatol. 2018 Dec;70(12):2077-2086
pubmed: 29953750
Biochemistry. 1994 Nov 29;33(47):14144-55
pubmed: 7947826
Cell Signal. 2011 Jan;23(1):135-44
pubmed: 20807568
Diabetes. 2005 Nov;54(11):3190-7
pubmed: 16249444
Nature. 2000 Nov 9;408(6809):211-6
pubmed: 11089976
iScience. 2023 May 19;26(6):106923
pubmed: 37283810

Auteurs

Liujun Chen (L)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Lisha Li (L)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Donghong Cui (D)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yiheng Huang (Y)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Haibin Tong (H)

College of Life and Environment Sciences, Wenzhou University, Wenzhou, Zhejiang, China.

Haleh Zabihi (H)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Shuxia Wang (S)

Department of Cardiology, The General Hospital of Chinese PLA, Beijing, China.

Yadan Qi (Y)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Ted Lakowski (T)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Lin Leng (L)

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Suixin Liu (S)

Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital of Central South University, Changsha, China.

Hong Wu (H)

Institute of Cardiovascular Disease, Henan University of Chinese Medicine, Zhengzhou, Henan, China.

Lawrence H Young (LH)

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Richard Bucala (R)

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Dake Qi (D)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Division of Biomedical Sciences, Faculty of Medicine, Memorial University, St. John's, NL, Canada. Electronic address: dake.qi@umanitoba.ca.

Classifications MeSH